These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17208287)

  • 1. TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization.
    Sato H; Silveira L; Fingerlin T; Dockstader K; Gillespie M; Lagan AL; Lympany P; Sawyer RT; du Bois RM; Welsh KI; Maier LA
    J Allergy Clin Immunol; 2007 Mar; 119(3):687-96. PubMed ID: 17208287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease.
    Maier LA; Sawyer RT; Bauer RA; Kittle LA; Lympany P; McGrath D; Dubois R; Daniloff E; Rose CS; Newman LS
    Am J Respir Crit Care Med; 2001 Oct; 164(7):1192-9. PubMed ID: 11673208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP.
    Sawyer RT; Parsons CE; Fontenot AP; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Newman LS
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):122-30. PubMed ID: 14975942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-alpha polymorphisms in chronic beryllium disease and beryllium sensitization.
    McCanlies EC; Schuler CR; Kreiss K; Frye BL; Ensey JS; Weston A
    J Occup Environ Med; 2007 Apr; 49(4):446-52. PubMed ID: 17426528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization.
    McCanlies EC; Ensey JS; Schuler CR; Kreiss K; Weston A
    Am J Ind Med; 2004 Aug; 46(2):95-103. PubMed ID: 15273960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major histocompatibility locus genetic markers of beryllium sensitization and disease.
    Saltini C; Richeldi L; Losi M; Amicosante M; Voorter C; van den Berg-Loonen E; Dweik RA; Wiedemann HP; Deubner DC; Tinelli C
    Eur Respir J; 2001 Oct; 18(4):677-84. PubMed ID: 11716174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity.
    Rogliani P; Amicosante M; Berretta F; Dotti C; Bocchino M; O'Donnell KM; Saltini C
    Int J Immunopathol Pharmacol; 2004; 17(2 Suppl):3-10. PubMed ID: 15345185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.
    Tinkle SS; Kittle LA; Newman LS
    J Immunol; 1999 Sep; 163(5):2747-53. PubMed ID: 10453017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity.
    Rosenman KD; Rossman M; Hertzberg V; Reilly MJ; Rice C; Kanterakis E; Monos D
    Occup Environ Med; 2011 Jul; 68(7):487-93. PubMed ID: 21186201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-presentation of beryllium by BAL CD4+ T cells: T cell-T cell interactions and their potential role in chronic beryllium disease.
    Fontenot AP; Edwards DM; Chou YK; Mack DG; LaTocha D; Vandenbark AA; Burrows GG
    Eur J Immunol; 2006 Apr; 36(4):930-9. PubMed ID: 16552706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beryllium-induced TNF-alpha production is transcription-dependent in chronic beryllium disease.
    Sawyer RT; Fontenot AP; Barnes TA; Parsons CE; Tooker BC; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Hagman J; Newman LS
    Am J Respir Cell Mol Biol; 2007 Feb; 36(2):191-200. PubMed ID: 16980557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.
    Maier LA; McGrath DS; Sato H; Lympany P; Welsh K; Du Bois R; Silveira L; Fontenot AP; Sawyer RT; Wilcox E; Newman LS
    J Immunol; 2003 Dec; 171(12):6910-8. PubMed ID: 14662898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells.
    Amicosante M; Berretta F; Franchi A; Rogliani P; Dotti C; Losi M; Dweik R; Saltini C
    Eur Respir J; 2002 Nov; 20(5):1174-8. PubMed ID: 12449171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beryllium induces IL-2 and IFN-gamma in berylliosis.
    Tinkle SS; Kittle LA; Schumacher BA; Newman LS
    J Immunol; 1997 Jan; 158(1):518-26. PubMed ID: 8977230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease.
    Gaede KI; Amicosante M; Schürmann M; Fireman E; Saltini C; Müller-Quernheim J
    J Mol Med (Berl); 2005 May; 83(5):397-405. PubMed ID: 15750822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease.
    Tinkle SS; Newman LS
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1884-91. PubMed ID: 9412570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis.
    Maier LA; Sawyer RT; Tinkle SS; Kittle LA; Barker EA; Balkissoon R; Rose C; Newman LS
    Eur Respir J; 2001 Mar; 17(3):403-15. PubMed ID: 11405518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles.
    Wang Z; White PS; Petrovic M; Tatum OL; Newman LS; Maier LA; Marrone BL
    J Immunol; 1999 Aug; 163(3):1647-53. PubMed ID: 10415070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between IL-1A single nucleotide polymorphisms and chronic beryllium disease and beryllium sensitization.
    McCanlies EC; Yucesoy B; Mnatsakanova A; Slaven JE; Andrew M; Frye BL; Schuler CR; Kreiss K; Weston A
    J Occup Environ Med; 2010 Jul; 52(7):680-4. PubMed ID: 20595916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide attenuates beryllium-induced IFNgamma responses in chronic beryllium disease: evidence for mechanisms independent of IL-18.
    Barna BP; Dweik RA; Farver CF; Culver D; Yen-Lieberman B; Thomassen MJ
    Clin Immunol; 2002 May; 103(2):169-75. PubMed ID: 12027422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.